|

Ambrisentan Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Noorik Biopharmaceuticals AG1

Indications

  • Hepatorenal Syndrome1
  • Ascites Hepatic1
  • Liver Disease1
  • Acute Kidney Injury1
  • Liver Cirrhosis1

Other1 trial

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.